青青草原av-午夜视频免费看-免费久久久-中国av片-欧美一级欧美三级在线观看-火影忍者羞羞漫画-成av人片在线观看www-国产日本亚洲-欧美视频在线免费-日本韩国在线-在线日韩中文字幕-国产成人三级在线播放-久久福利在线-老司机免费精品视频-男人操女人逼逼视频-av大片免费-欧美精品第二页-操校花视频-欧美插插视频-优优色综合

熱門搜索:A549    293T 金黃色葡萄球菌 大腸桿菌 AKK菌
購物車 1 種商品 - 共0元
當前位置: 首頁 > ATCC代理 > Klebsiella pneumoniae (Schroeter) Trevisan
最近瀏覽歷史
聯系我們
  • 0574-87157013
  • mingzhoubio@163.com
  • 浙江省寧波市鎮海區莊市街道興莊路9號
  • 創e慧谷42號樓B幢401室
Klebsiella pneumoniae (Schroeter) Trevisan
Klebsiella pneumoniae (Schroeter) Trevisan
規格:
貨期:
編號:B161486
品牌:Mingzhoubio

標準菌株
定量菌液
DNA
RNA

規格:
凍干粉
斜面
甘油
平板


產品名稱 Klebsiella pneumoniae (Schroeter) Trevisan
商品貨號 B161486
Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Klebsiella pneumoniae
Strain Designations BK34786
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation Urine
Isolation Date 2010
Geographic Source United States
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -80°C or colder
Preceptrol® no
Annotated Genes AAC(3)-IV
aadA3
acrA
acrB
acrD
acrE
acrF
adeB
emrB
KPC-3
macB
mdsB
mdtB
mdtC
mexB
msbA
oqxA
oqxB
OXA-9
SHV-66
tolC
Type Strain no
MIC Range Susceptible
Amikacin: ≤16 µg/mL
Doripenem: ≤1 µg/mL


Intermediate
Cefepime: 4-8 µg/mL
Fosfomycin: 128 µg/mL


Resistant
Amoxicillin-clavulanate: ≥32/16 µg/mL
Aztreonam: ≥16 µg/mL
Ceftazidime: ≥16 µg/mL
Ceftriaxone: ≥4 µg/mL
Ciprofloxacin: ≥4 µg/mL
Imipenem: ≥4 µg/mL
Levofloxacin: ≥8 µg/mL
Meropenem: ≥4 µg/mL
Piperacillin-tazobactam: ≥128/4 µg/mL
Tetracycline: ≥16 µg/mL
Trimethoprim-sulfamethoxazole: ≥4/76 µg/mL


Comments This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor The Public Health Research Institute Center at the New Jersey Medical School, Rutgers
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- The Public Health Research Institute Center at the New Jersey Medical School, Rutgers
References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.

梅經理 17280875617 1438578920
胡經理 13345964880 2438244627
周經理 17757487661 1296385441
于經理 18067160830 2088210172
沈經理 19548299266 2662369050
李經理 13626845108 972239479